View graph of relations
  1. 2019
  2. Published
  3. Published
    Paulus, A., van Ewijk, P. A., Nascimento, E. B. M., De Saint-Hubert, M., Hendrikx, G., Vogg, A., ... Bauwens, M. (2019). Characterization of BAT activity in rats using invasive and non-invasive techniques. PLOS ONE, 14(5), 1-18. [0215852]. https://doi.org/10.1371/journal.pone.0215852
  4. 2018
  5. Published
  6. Published
  7. Published
  8. Published
    Habets, T. H. P. M., Hepkema, B. G., Kouprie, N., Schnijderberg, M. C. A., van Smaalen, T. C., Bungener, L. B., ... Vanderlocht, J. (2018). The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression. PLOS ONE, 13(9), [e0203381]. https://doi.org/10.1371/journal.pone.0203381
  9. Published
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
    Goldschmidt, H., Lokhorst, H. M., Mai, E. K., van der Holt, B., Blau, I. W., Zweegman, S., ... Sonneveld, P. (2018). Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMGHD-4 trial. Leukemia, 32(2), 383-390. https://doi.org/10.1038/leu.2017.211
  15. Published
  16. 2017
  17. Published
  18. Published
  19. Published
  20. Published
  21. 2016
  22. Published
    Nijhof, I. S., Franssen, L. E., Levin, M-D., Bos, G. M. J., Broijl, A., Klein, S. K., ... van de Donk, N. W. C. J. (2016). Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma. Blood, 128(19), 2297-2306. https://doi.org/10.1182/blood-2016-07-729236
  23. Published
  24. Published
  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
  30. 2015
  31. Published
  32. Published
  33. Published
  34. 2014
  35. Published
  36. Published
  37. Published
  38. 2012
  39. Published
  40. Published
  41. 2011
  42. Published
  43. Published
  44. 2010
  45. Published
  46. Published
    Van Elssen, C. H. M. J., Frings, P. W. H., Bot, F. J., Van de Vijver, K. K., Huls, M. B., Meek, B., ... Bos, G. M. J. (2010). Expression of aberrantly glycosylated Mucin-1 in ovarian cancer. Histopathology, 57(4), 597-606. https://doi.org/10.1111/j.1365-2559.2010.03667.x
  47. Published
  48. Published
  49. Published
  50. Published
  51. Published
    Meek, B., Cloosen, S., Borsotti, C., Van Elssen, C. H. M. J., Vanderlocht, J., Schnijderberg, M. C. A., ... Bos, G. M. J. (2010). In vitro-differentiated T/natural killer-cell progenitors derived from human CD34(+) cells mature in the thymus. Blood, 115(2), 261-264. https://doi.org/10.1182/blood-2009-05-223990
  52. Published
  53. 2007
  54. Published
  55. 2005
  56. Published
  57. Published
  58. Published
  59. 2004
  60. Published
  61. Published
  62. 1989
  63. Published